Synopsis
Synopsis
0
CEP/COS
0
JDMF
0
EU WC
0
KDMF
0
NDC API
0
VMF
0
Listed Suppliers
0
API
0
FDF
0
FDF Dossiers
0
FDA Orange Book
0
Europe
0
Canada
0
Australia
0
South Africa
0
Listed Dossiers
DRUG PRODUCT COMPOSITIONS
0
EDQM
0
USP
0
JP
0
Others
0
US Patents
0
US Exclusivities
0
Health Canada Patents
0
Data Compilation #PharmaFlow
0
Stock Recap #PipelineProspector
0
Weekly News Recap #Phispers
0
News #PharmaBuzz
US Medicaid
NA
Annual Reports
NA
Finished Drug Prices
NA
1. 25629-50-9
2. 3-(2-chlorophenyl)-5-methyl-1,2-oxazole-4-carbonyl Chloride
3. 4-isoxazolecarbonyl Chloride, 3-(2-chlorophenyl)-5-methyl-
4. Nsc 81237
5. 3-(2-chlorophenyl)-5-methylisoxazole-4-carbonylchloride
6. 3-(o-chlorophenyl)-5-methyl-4-isoxazole Carbonylchloride
7. 4-isoxazolecarbonyl Chloride, 3-(o-chlorophenyl)-5-methyl-
8. 3-(2-chlorophenyl)-5-methyl-4-isoxazolecarbonyl Chloride
9. Cimic Chloride
10. Nsc81237
11. Einecs 247-137-4
12. Schembl315858
13. Dtxsid60865238
14. Albb-021303
15. Zinc1574328
16. Bbl027862
17. Mfcd00020811
18. Nsc-81237
19. Stl382081
20. Akos009031100
21. Ncgc00253746-01
22. As-12221
23. Bp-10168
24. Db-046741
25. Ft-0613545
26. A817931
27. Sr-01000945031
28. Sr-01000945031-1
29. W-107231
30. F2190-0126
31. 3-(2-?hlorophenyl)-5-methylisoxazole-4-carbonyl Chloride
32. 3-(o-chlorophenyl)-5-methylisoxazole-4-carbonyl Chloride
33. 3-(2-chlorophenyl)-5-methyl-3-phenyl-4-chlorocarbonyl Isoxazole
| Molecular Weight | 256.08 g/mol |
|---|---|
| Molecular Formula | C11H7Cl2NO2 |
| XLogP3 | 3.6 |
| Hydrogen Bond Donor Count | 0 |
| Hydrogen Bond Acceptor Count | 3 |
| Rotatable Bond Count | 2 |
| Exact Mass | 254.9853839 g/mol |
| Monoisotopic Mass | 254.9853839 g/mol |
| Topological Polar Surface Area | 43.1 Ų |
| Heavy Atom Count | 16 |
| Formal Charge | 0 |
| Complexity | 275 |
| Isotope Atom Count | 0 |
| Defined Atom Stereocenter Count | 0 |
| Undefined Atom Stereocenter Count | 0 |
| Defined Bond Stereocenter Count | 0 |
| Undefined Bond Stereocenter Count | 0 |
| Covalently Bonded Unit Count | 1 |
ABOUT THIS PAGE
A 3-2-Chlorophenyl-5-Methylisoxazole-4-Carbonyl Chloride manufacturer is defined as any person or entity involved in the manufacture, preparation, processing, compounding or propagation of 3-2-Chlorophenyl-5-Methylisoxazole-4-Carbonyl Chloride, including repackagers and relabelers. The FDA regulates 3-2-Chlorophenyl-5-Methylisoxazole-4-Carbonyl Chloride manufacturers to ensure that their products comply with relevant laws and regulations and are safe and effective to use. 3-2-Chlorophenyl-5-Methylisoxazole-4-Carbonyl Chloride API Manufacturers are required to adhere to Good Manufacturing Practices (GMP) to ensure that their products are consistently manufactured to meet established quality criteria.
A 3-2-Chlorophenyl-5-Methylisoxazole-4-Carbonyl Chloride supplier is an individual or a company that provides 3-2-Chlorophenyl-5-Methylisoxazole-4-Carbonyl Chloride active pharmaceutical ingredient (API) or 3-2-Chlorophenyl-5-Methylisoxazole-4-Carbonyl Chloride finished formulations upon request. The 3-2-Chlorophenyl-5-Methylisoxazole-4-Carbonyl Chloride suppliers may include 3-2-Chlorophenyl-5-Methylisoxazole-4-Carbonyl Chloride API manufacturers, exporters, distributors and traders.
click here to find a list of 3-2-Chlorophenyl-5-Methylisoxazole-4-Carbonyl Chloride suppliers with USDMF, JDMF, KDMF, CEP, GMP, COA and API Price related information on PharmaCompass.
A 3-2-Chlorophenyl-5-Methylisoxazole-4-Carbonyl Chloride DMF (Drug Master File) is a document detailing the whole manufacturing process of 3-2-Chlorophenyl-5-Methylisoxazole-4-Carbonyl Chloride active pharmaceutical ingredient (API) in detail. Different forms of 3-2-Chlorophenyl-5-Methylisoxazole-4-Carbonyl Chloride DMFs exist exist since differing nations have different regulations, such as 3-2-Chlorophenyl-5-Methylisoxazole-4-Carbonyl Chloride USDMF, ASMF (EDMF), JDMF, CDMF, etc.
A 3-2-Chlorophenyl-5-Methylisoxazole-4-Carbonyl Chloride DMF submitted to regulatory agencies in the US is known as a USDMF. 3-2-Chlorophenyl-5-Methylisoxazole-4-Carbonyl Chloride USDMF includes data on 3-2-Chlorophenyl-5-Methylisoxazole-4-Carbonyl Chloride's chemical properties, information on the facilities and procedures used, and details about packaging and storage. The 3-2-Chlorophenyl-5-Methylisoxazole-4-Carbonyl Chloride USDMF is kept confidential to protect the manufacturer’s intellectual property.
click here to find a list of 3-2-Chlorophenyl-5-Methylisoxazole-4-Carbonyl Chloride suppliers with USDMF on PharmaCompass.
3-2-Chlorophenyl-5-Methylisoxazole-4-Carbonyl Chloride Active pharmaceutical ingredient (API) is produced in GMP-certified manufacturing facility.
GMP stands for Good Manufacturing Practices, which is a system used in the pharmaceutical industry to make sure that goods are regularly produced and monitored in accordance with quality standards. The FDA’s current Good Manufacturing Practices requirements are referred to as cGMP or current GMP which indicates that the company follows the most recent GMP specifications. The World Health Organization (WHO) has its own set of GMP guidelines, called the WHO GMP. Different countries can also set their own guidelines for GMP like China (Chinese GMP) or the EU (EU GMP).
PharmaCompass offers a list of 3-2-Chlorophenyl-5-Methylisoxazole-4-Carbonyl Chloride GMP manufacturers, exporters & distributors, which can be sorted by USDMF, JDMF, KDMF, CEP (COS), WC, API price, and more, enabling you to easily find the right 3-2-Chlorophenyl-5-Methylisoxazole-4-Carbonyl Chloride GMP manufacturer or 3-2-Chlorophenyl-5-Methylisoxazole-4-Carbonyl Chloride GMP API supplier for your needs.
A 3-2-Chlorophenyl-5-Methylisoxazole-4-Carbonyl Chloride CoA (Certificate of Analysis) is a formal document that attests to 3-2-Chlorophenyl-5-Methylisoxazole-4-Carbonyl Chloride's compliance with 3-2-Chlorophenyl-5-Methylisoxazole-4-Carbonyl Chloride specifications and serves as a tool for batch-level quality control.
3-2-Chlorophenyl-5-Methylisoxazole-4-Carbonyl Chloride CoA mostly includes findings from lab analyses of a specific batch. For each 3-2-Chlorophenyl-5-Methylisoxazole-4-Carbonyl Chloride CoA document that a company creates, the USFDA specifies specific requirements, such as supplier information, material identification, transportation data, evidence of conformity and signature data.
3-2-Chlorophenyl-5-Methylisoxazole-4-Carbonyl Chloride may be tested according to a variety of international standards, such as European Pharmacopoeia (3-2-Chlorophenyl-5-Methylisoxazole-4-Carbonyl Chloride EP), 3-2-Chlorophenyl-5-Methylisoxazole-4-Carbonyl Chloride JP (Japanese Pharmacopeia) and the US Pharmacopoeia (3-2-Chlorophenyl-5-Methylisoxazole-4-Carbonyl Chloride USP).
LOOKING FOR A SUPPLIER?
